3 Day MBA Orphan Drugs
May 14-16, 2012
Imagine if you could master the orphan drug industry, in just three days…
With around 7000 known orphan diseases, around 200 products that have received official orphan drug designation, of which less than 100 have market approval in Europe, the orphan drug industry is potentially big business, but only for those who fully understand it.
In the 3 Day MBA in Orphan Drugs, you’ll explore all the critical issues and challenges in the industry from a global perspective. At the end of the three days, you’ll be able to better position your organisation to compete effectively in today’s fast-changing environment.
Day 1: Orphan drug fundamentals
Day 2: Developing and administering an orphan drug
Day 3: Launching an orphan drug